Exploring S1 plasticity and probing S1′ subsite of mammalian aminopeptidase N/CD13 with highly potent and selective aminobenzosuberone inhibitors-Reference-Cited by-同舟云学术

Exploring S1 plasticity and probing S1′ subsite of mammalian aminopeptidase N/CD13 with highly potent and selective aminobenzosuberone inhibitors

Published:2015-07 Issue:13 Volume:23 Page:3192-3207
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Revelant Germain,Al-Lakkis-Wehbe Mira,Schmitt Marjorie,Alavi Sarah,Schmitt Céline,Roux Lionel,Al-Masri Mounir,Schifano-Faux Nadège,Maiereanu Carmen,Tarnus Céline,Albrecht Sébastien

Funder

Ligue Contre le Cancer

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference31 articles.

1. 2nd ed;Barret,2004

2. Preparation of leucine aminopeptidase free of endopeptidase activity

3. CD13/APN is activated by angiogenic signals and is essential for capillary tube formation

4. CD13/APN regulates endothelial invasion and filopodia formation

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bufotalin inhibits porcine kidney cortex aminopeptidase N and is cytotoxic to APN+ tumor cells;Pure and Applied Chemistry;2023-05-09

2. Mammalian aminopeptidase A: biochemical characteristics, physiological roles and physiopathological implications;Pure and Applied Chemistry;2023-05-03

3. Marine Invertebrates: A Promissory Still Unexplored Source of Inhibitors of Biomedically Relevant Metallo Aminopeptidases Belonging to the M1 and M17 Families;Marine Drugs;2023-04-28

4. Bufadienolides preferentially inhibit aminopeptidase N among mammalian metallo-aminopeptidases; relationship with effects on human melanoma MeWo cells;International Journal of Biological Macromolecules;2023-02

5. Synthetic Approaches and Pharmacological Attributes of Benzosuberone Skeleton;Mini-Reviews in Medicinal Chemistry;2023-01